Yasushi Shigeoka Selected Research

Oral Administration

6/2021

Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Shigeoka Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 03/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2009 - 01/2003
4	Breast Neoplasms (Breast Cancer) 06/2021 - 03/2008
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2010 - 04/2008
3	Lung Neoplasms (Lung Cancer) 10/2007 - 06/2004
3	Adenocarcinoma of Lung 03/2005 - 03/2004
2	Neutropenia 03/2009 - 10/2007
2	Carcinoma (Carcinomatosis) 11/2005 - 10/2003
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019
1	Nausea 08/2019
1	Vomiting 08/2019
1	Bone Resorption 01/2015
1	Asthma (Bronchial Asthma) 07/2009
1	Respiratory Hypersensitivity 07/2009
1	Fever (Fevers) 03/2009
1	Disease Progression 04/2008
1	Leukopenia 10/2007
1	Diarrhea 10/2007
1	Hypersensitivity (Allergy) 01/2007
1	Embryonal Carcinoma 11/2005
1	Neoplasm Metastasis (Metastasis) 11/2005
1	Pneumonia (Pneumonitis) 01/2004
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2003
1	Carcinogenesis 10/2003

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 03/2008 - 01/2003
3	Cisplatin (Platino)FDA LinkGeneric 04/2008 - 10/2003
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2010 - 03/2005
2	amrubicinIBA 01/2010 - 03/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2009 - 11/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2008 - 10/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2008 - 11/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2008 - 01/2007
2	Retinoblastoma ProteinIBA 01/2007 - 06/2004
1	Trifluridine (Viroptic)FDA LinkGeneric 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	trifluridine tipiracil drug combinationIBA 10/2019
1	AnthracyclinesIBA 08/2019
1	NitrogenIBA 01/2015
1	Diphosphonates (Bisphosphonates)IBA 01/2015
1	Zoledronic Acid (Zometa)FDA Link 01/2015
1	Mevalonic Acid (Mevalonate)IBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 07/2009
1	OvalbuminIBA 07/2009
1	Leukotriene B4IBA 07/2009
1	Tyrosine Kinase InhibitorsIBA 03/2009
1	UracilIBA 03/2009
1	TegafurIBA 03/2009
1	Trastuzumab (Herceptin)FDA Link 03/2008
1	GlucocorticoidsIBA 01/2007
1	Granisetron (Kytril)FDA LinkGeneric 01/2006
1	Docetaxel (Taxotere)FDA Link 01/2006
1	Monoclonal AntibodiesIBA 11/2005
1	acarboxyprothrombin (PIVKA)IBA 11/2005
1	Histone Deacetylase InhibitorsIBA 03/2005
1	romidepsin (FK228)FDA Link 03/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2004
1	CurcuminIBA 03/2004
1	Catechin (Z 7300)IBA 03/2004
1	caffeic acid phenethyl esterIBA 03/2004
1	sulindac sulfideIBA 03/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2004
1	AntioxidantsIBA 12/2003
1	Biomarkers (Surrogate Marker)IBA 12/2003
1	VitaminsIBA 12/2003
1	8-Hydroxy-2'-DeoxyguanosineIBA 12/2003
1	Phosphotransferases (Kinase)IBA 10/2003
1	Y 27632IBA 10/2003
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2003

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 06/2021 - 11/2004
3	Therapeutics 01/2004 - 01/2003
1	Oral Administration 06/2021
1	Neoadjuvant Therapy 01/2015